Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-014418
Filing Date
2023-04-25
Accepted
2023-04-25 16:36:10
Documents
3
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A def_14a_-_proxy_notice_n.htm DEF 14A 36072
2 GRAPHIC img90418501_0.jpg GRAPHIC 1786255
3 GRAPHIC img90418501_1.jpg GRAPHIC 866862
  Complete submission text file 0000950170-23-014418.txt   3690572
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39864 | Film No.: 23845381
SIC: 8000 Services-Health Services